These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 10709119

  • 21. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity.
    Bader D, Kugelman A, Maor-Rogin N, Weinger-Abend M, Hershkowitz S, Tamir A, Lanir A, Attias D, Barak M.
    J Perinatol; 2001 Jun; 21(4):215-20. PubMed ID: 11533837
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Anemia of prematurity: risk factors influencing red cell transfusions].
    Zuppa AA, Mazzotta M, Maragliano G, Girlando P, Florio MG, Tortorolo G.
    Minerva Pediatr; 1995 Sep; 47(1-2):13-8. PubMed ID: 7791703
    [Abstract] [Full Text] [Related]

  • 26. Effects of recombinant human erythropoietin in infants with very low birth weights.
    Samanci N, Ovali F, Dagoglu.
    J Int Med Res; 1996 Sep; 24(2):190-8. PubMed ID: 8737229
    [Abstract] [Full Text] [Related]

  • 27. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].
    Javier Manchón G, Natal Pujol A, Coroleu Lletget W, Zuasnábar Cotro A, Badía Barnusell J, Juncá Piera J, Bel Comós J, Sábado Alvarez C, Prats Viñas J.
    An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
    Spicka I, Haber J, Petruzelka L, Kolesková E, Sálková J, Straub J, Zounar R, Klener P.
    Cas Lek Cesk; 1996 Jul 14; 135(14):450-3. PubMed ID: 8925545
    [Abstract] [Full Text] [Related]

  • 30. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P, Shankaran S, Krishnan RG.
    J Perinatol; 1998 Jul 14; 18(3):173-7. PubMed ID: 9659643
    [Abstract] [Full Text] [Related]

  • 31. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
    Rigourd V, Kieffer F, Dommergues MA, Ayachi A, Assaf Z, Mohamed I, Voyer M, Magny JF.
    Arch Pediatr; 2004 Apr 14; 11(4):319-26. PubMed ID: 15051090
    [Abstract] [Full Text] [Related]

  • 32. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC, Dame C, Vonthein R, Koller B, Arri S, Wolf M, Bucher HU.
    Pediatrics; 2008 Aug 14; 122(2):375-82. PubMed ID: 18676556
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD, James KM, Levy JK, Browne JK, Miller A, Lobingier RT, Egrie JC.
    J Am Vet Med Assoc; 1998 Feb 15; 212(4):521-8. PubMed ID: 9491159
    [Abstract] [Full Text] [Related]

  • 37. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis.
    Kotto-Kome AC, Garcia MG, Calhoun DA, Christensen RD.
    J Perinatol; 2004 Jan 15; 24(1):24-9. PubMed ID: 14726934
    [Abstract] [Full Text] [Related]

  • 38. Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants.
    Tempera A, Stival E, Piastra M, De Luca D, Ottaviano C, Tramontozzi P, Marconi M, Cafforio C, Marcozzi P, Rossi N, Buffone E.
    J Matern Fetal Neonatal Med; 2011 Aug 15; 24(8):1060-4. PubMed ID: 21250913
    [Abstract] [Full Text] [Related]

  • 39. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A, Hayde M, Hayn M, Herkner K, Lombard KA, Lubec G, Weninger M, Widness JA.
    Pediatrics; 2001 Jan 15; 107(1):78-85. PubMed ID: 11134438
    [Abstract] [Full Text] [Related]

  • 40. Comparison of 2 iron doses in infants receiving recombinant human erythropoietin therapy.
    Nazir S, Peverini RL, Deming DD, Hopper AO, Vyhmeister NR.
    Arch Pediatr Adolesc Med; 2002 Jun 15; 156(6):540-4. PubMed ID: 12038884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.